Facebook Instagram Linkedin Youtube
Home Tags Alligator aktier

Tag: Alligator aktier

Alligator to maximise immuno-oncology innovation

Alligator to maximise immuno-oncology innovation

Clinical effects Alligator's bispecific 4-1bb agonist

Clinical effects observed with Alligator’s 4-1BB agonist

SørenBregenholt, CEO AlligatorBioscience

Alligator meets primary endpoint with CD40 agonist in pancreatic cancer

Alligator_Strong_Q3

Strong Q3 performance for Alligator Bioscience

Alligator CD40 durable

Phase II results indicate durability of response for Alligator’s CD40 agonist

Alligator orphan drug designation

Alligator Bioscience awarded Orphan Drug Designation for mitazalimab

AlligatorBioscienceCEOinterview_SørenBregenholt

Alligator Bioscience’s CEO on the rights issue

Soren Bregenholt, CEO Alligator Bioscience

BioStock Investor Pitch: Alligator Bioscience

© BioStock 2024